Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
adults with type 2 diabetes are now eligible for GLP-1 or SGLT-2 therapies, demonstrating guideline-driven expansion of demand
Book a Bridge eligibility visit Key takeaways The Medicare GLP-1 Bridge is a CMS demonstration program, live July 1, 2026 through December 31, 2027, that gives eligible Medicare Part D beneficiaries access to specific GLP-1 medications for a $50 per month medication copay
Transform Your Health with Glowise Lose weight, eat smarter, and stay consistentwhether you're tracking calories, managing protein, following keto/low-carb, or pairing nutrition with GLP-1 support
However, improper usesuch as increasing the dosage too quicklycan reduce its effectiveness and lead to negative side effects
If you don't qualify for treatment, you won't be charged the ongoing membership fee
Medication combinations require special attention
